Ingo Weigmann
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes Treatment and Management 4
-
- Renal function and acid-base balance 1
- Co-authors
- M Hanefeld (2 shared papers)Andreas L. Birkenfeld (2 shared papers)Frank Pistrosch (2 shared papers)Elena Henkel (1 shared paper)Stefan Richard Bornstein (1 shared paper)Jan Sradnick (1 shared paper)Bernhard Schipp (1 shared paper)Dorothea Schipp (1 shared paper)
- Journals
- The Lancet (3 papers)Diabetologia (1 paper)JAMA (1 paper)Diabetes Care (1 paper)JAMA Cardiology (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Ingo Weigmann
10 papers receiving 2.9k citations
Ingo Weigmann's Hit Papers
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 2.3k
- Cardiology and Cardiovascular Medicine 435
- Pharmacology 323
- Nephrology 120
- Surgery 637
Countries citing papers authored by Ingo Weigmann
This map shows the geographic impact of Ingo Weigmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Weigmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Weigmann more than expected).
Fields of papers citing papers by Ingo Weigmann
This network shows the impact of papers produced by Ingo Weigmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Weigmann. The network helps show where Ingo Weigmann may publish in the future.
Co-authors
The 17 scholars most cited alongside Ingo Weigmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hit paper breakdown → | 2019 | 2307 |
| 2 | Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 492 |
| 3 | 2019 | 159 | |
| 4 | 2020 | 30 | |
| 5 | 2021 | 17 | |
| 6 | 2017 | 13 | |
| 7 | 2021 | 13 | |
| 8 | 2026 | 4 | |
| 9 | [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo]. | 1998 | 2 |
| 10 | 2005 | 1 |
About Ingo Weigmann
Ingo Weigmann is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Nutrition and Dietetics, Cardiology and Cardiovascular Medicine and Surgery, having authored 10 papers that have together received 3.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Vitamin K Research Studies (1 paper), Renal function and acid-base balance (1 paper), Lipoproteins and Cardiovascular Health (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Cardiology and Cardiovascular Medicine (435 citations), Pharmacology (323 citations), Nephrology (120 citations) and Surgery (637 citations). Ingo Weigmann has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include M Hanefeld, Andreas L. Birkenfeld, Frank Pistrosch, Elena Henkel, Stefan Richard Bornstein, Jan Sradnick, Bernhard Schipp, Dorothea Schipp, Werner Martin Herrmann and Werner Wierich. Their work appears in journals such as The Lancet, Diabetologia, JAMA, Diabetes Care and JAMA Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.